ARTICLE | Company News
Alexion acquires Prolifaron
September 25, 2000 7:00 AM UTC
ALXN acquired Prolifaron (San Diego, Calif.), a combinatorial human antibody library technology company, for $41 million in stock. Prolifaron has been renamed Alexion Antibody Technologies and will be...